Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2020
Mar. 31, 2019
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]        
Net revenues $ 9,943,104 $ 6,976,115 $ 20,521,120 $ 13,347,924
Cost of sales 2,506,606 2,367,264 5,815,527 4,094,993
Gross profit 7,436,498 4,608,851 14,705,593 9,252,931
Operating expenses:        
Research and development 3,930,260 2,910,587 9,230,234 5,272,410
Selling, general and administrative 3,805,916 3,822,854 7,559,430 7,116,838
Total operating expenses 7,736,176 6,733,441 16,789,664 12,389,248
Operating loss (299,678) (2,124,590) (2,084,071) (3,136,317)
Non-operating (expenses) income:        
Interest expense (1,164,962) (1,258,272) (2,306,387) (2,536,695)
Change in fair value of derivative liabilities 469,000 (628,000) 75,000 (403,000)
Other income (expense), net 51,991 1,994 (10,035) 10,844
Total non-operating expenses (643,971) (1,884,278) (2,241,422) (2,928,851)
Loss before income taxes (943,649) (4,008,868) (4,325,493) (6,065,168)
Income tax (benefit) expense (133,140) 25,167 (209,883) 117,665
Net loss $ (810,509) $ (4,034,035) $ (4,115,610) $ (6,182,833)
Net loss per basic and diluted common share outstanding $ (0.01) $ (0.06) $ (0.06) $ (0.10)
Basic and diluted weighted average common shares outstanding 65,367,493 62,767,258 65,202,103 62,659,352